76 lines
3.6 KiB
Plaintext
76 lines
3.6 KiB
Plaintext
Newsgroups: alt.drugs
|
|
|
|
> I've been taking Gingko as a vitamin supplement and have noticed a marked
|
|
> increase in the level of intensity I am able to think. It's supposed to
|
|
> be a "smart" drug, but I didn't realize the effects were so apparent.
|
|
> Supposedly,
|
|
|
|
From Smart Drugs and Nutrients:
|
|
|
|
GINKGO BILOBA: A Nootropic Herb?
|
|
|
|
Gingko biloba is the oldest species of tree known, dating back 300 years.
|
|
Extracts from the leaves of the gingko biloba tree have been used by Chin-
|
|
ese medicine for thousands of years. European physicians write over 1.2
|
|
million prescriptions per month for it. Gingko biloba is used to improve
|
|
cerebral circulation, mental alertness, and overall brain functioning.
|
|
|
|
More than 34 human studies on gingko have been published since 1975, show-
|
|
ing that gingko works by increasing blood flow throughout the body and
|
|
brain. Gingko increases the productions of adenosine triphosphate (ATP,
|
|
the universal energy molecule). It also improves the brain's ability to
|
|
metabolize glucose, prevents platelet aggregation inside arterial walls by
|
|
keeping them flexible, improves the transmission of nerve signals, and
|
|
acts as a powerful antioxidant.
|
|
|
|
Gingko biloba leaf is effective for people with symptoms of reduced blood
|
|
flow to the brain and extremities. It has been shown to be helpful with
|
|
many of the complaints of the elderly such as: memory loss, slow thinking
|
|
and reasoning, depression, dizziness, ringing in the ears, headaches, and
|
|
senile macular degeneration (a major cause of blindness).
|
|
|
|
One study even shows significant improvement in people who have both Park-
|
|
ingson's and Alzheimer's disease. In this study 25 people w/ Parkingson's
|
|
disease and signs of Alzheimer's disease were given gingko extract daily
|
|
for one year. They were tested with standard tests, clinical evaluations,
|
|
and a new computerized EEG. The scores improved significantly.
|
|
|
|
CITE: Funfgeld, E.W. "A natural and broad spectrum nootropic substance
|
|
treatment of SDAT - the gingko biloba extract".
|
|
from Progress in Clinical and Biological Research, 1989, 317
|
|
(pp 1247-1260)
|
|
|
|
One study does not prove that Gingko biloba is efficacious in the treatment
|
|
of these diseases. However, gingko is safe, inexpensive and easily obtain-
|
|
ed, and people with Parkingsons and/or Alzheimer's might consider experi-
|
|
menting with it.
|
|
|
|
PRECAUTIONS: No negative effects have been reported in the literature even
|
|
in very large quantities.
|
|
|
|
DOSAGE: Most research has been done with a gingko biloba extract which con-
|
|
tained a 24% concentration of flavinoid extract. At this strength, the
|
|
usual dosage is 120-160mg per day taken in three divided doses. However,
|
|
many gingko products are lower in potency, and may require dosages as high
|
|
as 1000mg per day. Three to six months is probably needed to evaluate the
|
|
results.
|
|
|
|
Your welcome. Buy the book, (and their sequal, smart drugs II):
|
|
|
|
"Smart Drugs and Nutrients" by Ward Dean & John Morgenthaler (1990)
|
|
ISBN# 0-9627418-9-2 ($12.95)
|
|
|
|
"Smart Drugs II" by Ward Dean / John Morgenthaler / Steven Wm. Fowkes (1993)
|
|
ISBN# 0-9627418-7-6 ($14.95)
|
|
|
|
SD2 covers totally different material than the first book:
|
|
Deprenyl, Melatonin, Milacemide, Nimodipine, Phosphatidylserine,
|
|
Pregnenolone, Ondansetron and Zatosetron.
|
|
|
|
The first book has almost everything else you've ever heard of:
|
|
Pyrrolidone types (Piracetam, Oxiracetam), Hydergine, Vasopressin,
|
|
Fipexide, Vinopocetine, Acetyl-L-Carnitine, Centrophenoxine,
|
|
Choline, AL721, DHEA, DMAE, Gerovital GH-3, Gingko, Ginseng,
|
|
Idebenone (CoQ10), Phenytoin (dilantin), Inderal, Vincamine, etc.
|
|
|